Los Angeles Capital Management LLC Has $1.56 Million Holdings in Addus HomeCare Co. (NASDAQ:ADUS)

Los Angeles Capital Management LLC raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 32.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,711 shares of the company’s stock after buying an additional 2,879 shares during the period. Los Angeles Capital Management LLC’s holdings in Addus HomeCare were worth $1,558,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Ellsworth Advisors LLC bought a new position in Addus HomeCare in the 2nd quarter valued at $598,000. Quadrature Capital Ltd bought a new position in shares of Addus HomeCare in the first quarter valued at about $1,557,000. Lord Abbett & CO. LLC bought a new position in shares of Addus HomeCare in the first quarter valued at about $8,274,000. SG Americas Securities LLC acquired a new position in Addus HomeCare during the 2nd quarter worth about $842,000. Finally, Dimensional Fund Advisors LP grew its holdings in Addus HomeCare by 0.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after acquiring an additional 5,421 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on ADUS. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. TD Cowen upped their price objective on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada decreased their price objective on Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Oppenheimer raised their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Trading Down 2.3 %

NASDAQ ADUS opened at $123.29 on Thursday. Addus HomeCare Co. has a 12 month low of $83.46 and a 12 month high of $136.12. The company has a market capitalization of $2.24 billion, a PE ratio of 28.21, a P/E/G ratio of 2.20 and a beta of 1.04. The stock has a 50-day simple moving average of $129.27 and a 200 day simple moving average of $122.06.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the company posted $1.03 EPS. As a group, sell-side analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares in the company, valued at $429,165. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,917 shares of company stock worth $3,050,082. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.